drugset / Trial / NCT05250791

Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome

NCT05250791 ↗

Unknown 50 enrolled Imperial College London
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This feasibility (small) study aims to see if it is possible to run a large study looking at the effect of lidocaine on large bowel cancer recurrence after surgery in the NHS hospitals.

Timeline

Start
2023-02-02
Primary completion
2024-09-15
Completion
2024-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications